Bempedoic Acid + Ezetimibe Fixed-Dose Combination
1002FDC-053
Phase 3 other completed
Quick answer
Bempedoic Acid + Ezetimibe Fixed-Dose Combination for Hyperlipidemias is a Phase 3 program (other) at Esperion Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Esperion Therapeutics
- Indication
- Hyperlipidemias
- Phase
- Phase 3
- Modality
- other
- Status
- completed